Hydrogel Strategies for Female Reproduction Dysfunction

ACS Nano. 2024 Nov 5;18(44):30132-30152. doi: 10.1021/acsnano.4c05634. Epub 2024 Oct 22.

Abstract

Infertility is an important issue for human reproductive health, with over half of all cases of infertility associated with female factors. Dysfunction of the complex female reproductive system may cause infertility. In clinical practice, female infertility is often treated with oral medications and/or surgical procedures, and ultimately with assisted reproductive technologies. Owing to their excellent biocompatibility, low immunogenicity, and adjustable mechanical properties, hydrogels are emerging as valuable tools in the reconstruction of organ function, supplemented by tissue engineering techniques to increase their structure and functionality. Hydrogel-based female reproductive reconstruction strategies targeting the pathological mechanisms of female infertility may provide alternatives for the treatment of ovarian, endometrium/uterine, and fallopian tube dysfunction. In this review, we provide a general introduction to the basic physiology and pathology of the female reproductive system, the limitations of current infertility treatments, and the lack of translation from animal models to human reproductive physiology. We further provide an overview of the current and future potential applications of hydrogels in the treatment of female reproductive system dysfunction, highlighting the great prospects of hydrogel-based strategies in the field of translational medicine, along with the significant challenges to be overcome.

Keywords: bioactive biomaterials; biomimetic ovarian follicle structure; endometrial receptivity; endometrium; fallopian tubes; female infertility; fertility restoration; hydrogel; ovaries; uterus.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Humans
  • Hydrogels* / chemistry
  • Infertility, Female* / therapy
  • Reproduction / drug effects
  • Tissue Engineering

Substances

  • Hydrogels